Basic Materials / Specialty ChemicalsNSE
$180.88
+0.36 (+0.19%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $231.3M · quality 57.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
52/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$48.2B
P/E
32.5x
↑EV/EBITDA
19.9x
↑ROE
9.5%
↑Gross Margin
29.2%
↑Debt/Equity
0.13
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+12.7%
FCF CAGR
—
FCF margin
1.6%
FCF / Net income
0.15x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $13.94B · net income $1.48B · FCF $225.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $13.94B | $13.94B | $14.18B | $10.87B | $9.74B |
| Net Income | $1.48B | $1.48B | $1.99B | $1.61B | $243.9M |
| EBITDA | $2.51B | $2.51B | $3.03B | $2.58B | $1.13B |
| EPS | 5.57 | 5.57 | 7.46 | 6.05 | 0.91 |
| Gross Margin | 29.2% | 29.2% | 32.3% | 30.1% | 23.0% |
| Operating Margin | 12.2% | 12.2% | 15.9% | 16.5% | 4.4% |
| Net Margin | 10.6% | 10.6% | 14.0% | 14.8% | 2.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.13 | 0.13 | 0.19 | 0.19 | 0.27 |
| Current Ratio | 6.16 | 6.16 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $225.7M | $225.7M | $231.3M | $350.1M | $-8.1M |
| Returns | |||||
| ROE | 9.5% | 9.5% | 14.8% | 14.2% | 2.5% |
| Valuation | |||||
| P/E | 32.47 | 32.47 | 26.11 | 49.06 | 145.71 |
| EV/EBITDA | 19.92 | 19.92 | 17.93 | 31.48 | 33.46 |
| P/B | 3.09 | 3.09 | 3.86 | 6.96 | 3.64 |
| Growth & Yield | |||||
| Revenue Growth | -1.7% | -1.7% | 30.4% | 11.6% | — |
| EPS Growth | -25.3% | -25.3% | 23.3% | 564.8% | — |
| Dividend Yield | 0.1% | 0.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
42.3%
EPS terminal req.
$16.05
Spread vs growth
-67.6%
5Y implied EPS CAGR
28.4%
EPS terminal req.
$19.42
Spread vs growth
-53.7%
10Y implied EPS CAGR
18.8%
EPS terminal req.
$31.28
Spread vs growth
-44.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+1.4%
Start / end P/E
25.7x → 34.9x
EPS bridge
7.46 → 5.57
Residual
-9.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.